T. Rowe Price Associates
HSTM icon

T. Rowe Price Associates’s HealthStream HSTM Stock Holding History

T. Rowe Price Associates’s Portfolio HSTM Stock Details HSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$612K Buy
29,536
+4,239
+17% +$90.3K ﹤0.01% 2360
2025
Q4 		$584K Buy
25,297
+3,067
+14% +$77.1K ﹤0.01% 2321
2025
Q3 		$628K Buy
22,230
+566
+3% +$15.6K ﹤0.01% 2283
2025
Q2 		$600K Buy
21,664
+1,612
+8% +$47.6K ﹤0.01% 2219
2025
Q1 		$646K Buy
20,052
+1,267
+7% +$41.1K ﹤0.01% 2157
2024
Q4 		$598K Buy
18,785
+1,550
+9% +$47.8K ﹤0.01% 2211
2024
Q3 		$498K Buy
17,235
+260
+2% +$7.45K ﹤0.01% 2242
2024
Q2 		$474K Buy
16,975
+797
+5% +$21.2K ﹤0.01% 2209
2024
Q1 		$432K Buy
16,178
+918
+6% +$24.6K ﹤0.01% 2268
2023
Q4 		$413K Buy
15,260
+412
+3% +$10.2K ﹤0.01% 2256
2023
Q3 		$321K Buy
14,848
+665
+5% +$14.7K ﹤0.01% 2306
2023
Q2 		$349K Buy
14,183
+333
+2% +$8.26K ﹤0.01% 2296
2023
Q1 		$376K Buy
13,850
+400
+3% +$9.98K ﹤0.01% 2233
2022
Q4 		$334K Buy
13,450
+388
+3% +$9.31K ﹤0.01% 2332
2022
Q3 		$278K Buy
13,062
+1,379
+12% +$31.4K ﹤0.01% 2414
2022
Q2 		$254K Buy
11,683
+141
+1% +$2.81K ﹤0.01% 2512
2022
Q1 		$230K Buy
+11,542
New +$261K ﹤0.01% 2660
2021
Q4 		– Sell
-7,253
Closed -$207K – 3008
2021
Q3 		$207K Sell
7,253
-9,101
-56% -$266K ﹤0.01% 2712
2021
Q2 		$457K Sell
16,354
-6,260
-28% -$157K ﹤0.01% 2426
2021
Q1 		$505K Sell
22,614
-26
-0.1% -$620 ﹤0.01% 2360
2020
Q4 		$494K Buy
+22,640
New +$455K ﹤0.01% 2243
2020
Q3 		– Sell
-11,240
Closed -$249K – 2604
2020
Q2 		$249K Buy
11,240
+57
+0.5% +$1.32K ﹤0.01% 2301
2020
Q1 		$268K Buy
11,183
+140
+1% +$3.52K ﹤0.01% 2231
2019
Q4 		$300K Sell
11,043
-1,965
-15% -$54K ﹤0.01% 2312
2019
Q3 		$337K Buy
13,008
+174
+1% +$4.67K ﹤0.01% 2241
2019
Q2 		$332K Buy
12,834
+16
+0.1% +$420 ﹤0.01% 2273
2019
Q1 		$360K Buy
12,818
+70
+0.5% +$1.84K ﹤0.01% 2239
2018
Q4 		$308K Sell
12,748
-3,049
-19% -$79.1K ﹤0.01% 2273
2018
Q3 		$490K Buy
15,797
+156
+1% +$4.66K ﹤0.01% 2157
2018
Q2 		$427K Buy
15,641
+28
+0.2% +$743 ﹤0.01% 2208
2018
Q1 		$388K Buy
15,613
+50
+0.3% +$1.2K ﹤0.01% 2182
2017
Q4 		$360K Buy
15,563
+5,590
+56% +$132K ﹤0.01% 2217
2017
Q3 		$233K Hold
9,973
– – ﹤0.01% 2360
2017
Q2 		$262K Buy
9,973
+3
+0% +$82 ﹤0.01% 2290
2017
Q1 		$242K Buy
+9,970
New +$232K ﹤0.01% 2333
2013
Q4 		– Sell
-236,473
Closed -$8.96M – 2498
2013
Q3 		$8.96M Sell
236,473
-149,400
-39% -$4.87M ﹤0.01% 1301
2013
Q2 		$9.77M Buy
+385,873
New +$9.31M ﹤0.01% 1256

Other funds holding HSTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates's HSTM Position: Q1 2026 in Review

T. Rowe Price Associates increased its HealthStream (HSTM) stake by 17% in Q1 2026, buying an estimated $90.3K and bringing the position to 29,536 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

T. Rowe Price Associates first reported a position in HSTM in Q2 2013 and has held it in 37 quarters since. The position peaked at $9.77M in Q2 2013. 197 funds tracked by Wall St. Rank hold HSTM as of Q1 2026.

  • T. Rowe Price Associates held 29,536 shares of HealthStream worth $612K as of Q1 2026.
  • T. Rowe Price Associates bought 4,239 HealthStream shares in Q1 2026, an estimated $90.3K.
  • HealthStream made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2360 holding.
  • T. Rowe Price Associates first reported a position in HealthStream in Q2 2013 and has held it in 37 quarters since.
  • T. Rowe Price Associates's HealthStream position peaked at $9.77M in Q2 2013.
  • 197 funds tracked by Wall St. Rank held HealthStream as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.